Last reviewed · How we verify
HF1K16
At a glance
| Generic name | HF1K16 |
|---|---|
| Sponsor | HighField Biopharmaceuticals Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluate the Safety, Tolerability and PK of HF1K16 in Healthy Volunteers (PHASE1)
- Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HF1K16 CI brief — competitive landscape report
- HF1K16 updates RSS · CI watch RSS
- HighField Biopharmaceuticals Corporation portfolio CI